“Outcomes of Gemcitabine, Vinorelbine, and Doxorubicin in Peripheral T-Cell Lymphoma”, acmcr, vol. 8, no. 3, pp. 92–96, May 2024, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22941